X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast Cancer
NCT02838238 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2016-07-20
Summary
Our study is a prospective, randomized phase II clinical trial, to compare the efficacy and safety profiles of single X versus placebo as adjuvant chemotherapy regimens for elder breast cancer patients.
Conditions
Interventions
- DRUG
- DRUG
Sponsors & Collaborators
-
Peking Union Medical College Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2020-01-31
Countries
- China
Study Locations
More Related Trials
-
Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer
NCT00352378 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy
NCT02879513 ·Status: UNKNOWN ·Phase: PHASE3
-
A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer
NCT00488722 ·Status: UNKNOWN ·Phase: NA
-
TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast Cancer
NCT01354522 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer
NCT00214864 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy
NCT07284836 ·Status: RECRUITING ·Phase: PHASE2
-
Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer
NCT03647514 ·Status: UNKNOWN ·Phase: NA
-
Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer
NCT01712893 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Cancer Patients
NCT07096869 ·Status: RECRUITING ·Phase: PHASE1
-
Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
NCT00002873 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neoadjuvant Effect of Albumin Binding Paclitaxel Compared With Common Paclitaxel in Breast Cancer：an Observational Single Center Study of Clinical Efficacy in Adjuvant Chemotherapy
NCT05636644 ·Status: UNKNOWN
-
Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer
NCT03994107 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery
NCT00589238 ·Status: TERMINATED ·Phase: PHASE2
-
Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy
NCT01314833 ·Status: COMPLETED ·Phase: PHASE3
-
Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer
NCT00516425 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer
NCT01648608 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy
NCT03423849 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer
NCT02846428 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study
NCT05287308 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer
NCT02613026 ·Status: COMPLETED ·Phase: PHASE3
-
Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer
NCT05251766 ·Status: UNKNOWN ·Phase: PHASE1
-
The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer
NCT03647280 ·Status: UNKNOWN ·Phase: NA
-
Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer
NCT02059876 ·Status: UNKNOWN ·Phase: PHASE2
-
Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
NCT00003893 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer
NCT00274456 ·Status: COMPLETED ·Phase: PHASE2